Skip to main content

Hls Therapeutics Inc(HLS-T)
TSX

Today's Change
Real-Time Last Update

HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Newswire.ca - Fri Apr 21, 2023

TORONTO, April 21, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular markets, announces that Tim Hendrickson, Chief Financial Officer, will present at the Bloom Burton & Co. Healthcare Investor Conference, which takes place Tuesday April 25 - Wednesday April 26, 2023 at the Metro Toronto Convention Centre, North Building, in downtown Toronto.

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe